Holland-Frei Cancer Medicine
The original reference resource for medical oncologists, radiation oncologists, internists, and allied specialties involved in the treatment of cancer patients, Holland-Frei Cancer Medicine covers the ever-expanding field of current cancer science and clinical oncology practice. In this new ninth edition an outstanding editorial team from world-renowned medical centers continue to hone the leading edge forged in previous editions, with timely information on biology, immunology, etiology, epidemiology, prevention, screening, pathology, imaging, and therapy.Holland-Frei Cancer Medicine, Ninth Edition, brings scientific principles into clinical…
Mehr
CHF 299.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V112:
Lieferbar in ca. 10-20 Arbeitstagen
Produktdetails
Weitere Autoren: Croce, Carlo M. / Hait, William N. / Hong, Waun Ki / Kufe, Donald W. / Piccart-Gebhart, Martine / Pollock, Raphael E. / Weichselbaum, Ralph R. / Wang, Hongyang / Holland, James F.
- ISBN: 978-1-118-93469-2
- EAN: 9781118934692
- Produktnummer: 19518007
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2017
- Seitenangabe: 2008 S.
- Auflage: 9. A.
Über den Autor
Robert C. Bast Jr, MD, Vice President for Translational Research, MD Anderson Cancer Center, Houston, TX, USACarlo M. Croce, MD, Distinguished University Professor, The John W. Wolfe Chair in Human Cancer Genetics, Professor and Chair, Department of Molecular Virology, Immunology and Medical Genetics, The Wexner Medical Center, The Ohio State University, Columbus, OH, USAWilliam Hait, MD, PhD, Global Head research and Development, Janssen pharmaceutical companies of Johnson and Johnson, NJ, USAWaun Ki Hong, MD, DMSc, Professor of Thoracic/Head and Neck Medical Oncology, American Cancer Society Professor, Samsung Distinguished University Chair in Cancer Medicine Emeritus, The University of Texas M.D.Anderson Cancer Center, Houston, TX, USADonald W. Kufe, MD, Distinguished Physician, Dana-Farber Cancer Institute, Professor of MedicineHarvard Medical School, Leader, Translational Pharmacology and Early Therapeutic Trials ProgramDana-Farber/Harvard Cancer Center, Boston, MA, USAMartine Piccart-Gebhart MD PhD, Professor of Oncology, Université Libre de Bruxelles (ULB), Head of the Medicine Department, Jules Bordet Institute, Brussels, BelgiumRaphael E. Pollock, MD, PhD, FACS, Professor and Director, Division of Surgical Oncology, Surgeon in Chief, James Comprehensive Cancer Center, Surgeon in Chief, The Ohio State University Health System, The Ohio State University Wexner Medical Center, Columbus, OH, USARalph R. Weichselbaum, MD, Daniel K. Ludwig Professor Chair Dept of Radiology and Cellular Oncology University of Chicago Hospital Director Chicago Tumor Institute, IL, USADr Hongyang Wang, Professor and Director, National Center for Liver Cancer, China; and Eastern Hepatobiliary Surgery Hospital, Shanghai, ChinaJames F. Holland, MD, ScD (hc), Distinguished Professor of Neoplastic Diseases, Director Emeritus of Derald H.Rutttenberg Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USAASSOCIATE EDITOR Fadlo R. Khuri, MD, Executive Associate Dean for Research, Emory University School of Medicine, Atlanta, GA, USA; President, the American University of Beirut, Beirut, Lebanon
5 weitere Werke von Robert C. Bast:
Bewertungen
Anmelden